Kuhlmann Shirley R.'s Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Sep 6, 2024
- Accession no.
- 0001062993-24-016277
- Filed
- Sep 6, 2024
- Trade date
- Sep 5-6, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $773.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuhlmann Shirley R.CIK 0001734919 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2024 | Common Stock | SSaleDisposed | −16,848 | $38.18 | −$643,256.64 | 122,561 | Direct | |
| Sep 5, 2024 | Common Stock | SSaleDisposed | −2,400 | $39.14 | −$93,936 | 120,161 | Direct | |
| Sep 6, 2024 | Common Stock | SSaleDisposed | −977 | $37.46 | −$36,598.42 | 119,184 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.